- Home
- EVR vs NBIX Comparison
EVR vs NBIX Comparison
Compare EVR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVR | NBIX |
|---|---|---|
| Founded | 1995 | 1992 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 13.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EVR | NBIX |
|---|---|---|
| Price | $329.71 | $127.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 21 |
| Target Price | ★ $344.00 | $175.95 |
| AVG Volume (30 Days) | 523.8K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.24 | $22.57 |
| Revenue Next Year | $15.48 | $9.56 |
| P/E Ratio | ★ $22.78 | $27.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $148.63 | $84.23 |
| 52 Week High | $388.71 | $160.18 |
Technical Indicators
Market Signals| Indicator | EVR | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 41.23 | 38.52 |
| Support Level | $305.01 | $122.14 |
| Resistance Level | $369.64 | $129.94 |
| Average True Range (ATR) | 18.54 | 4.50 |
| MACD | -4.33 | -0.98 |
| Stochastic Oscillator | 39.20 | 28.43 |
Price Performance
Historical ComparisonAbout EVR Evercore Inc.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.